Public Company News

WiMi Has Developed a Scalable Quantum Neural Network (SQNN) Technology Based on Multi-quantum-device Collaborative Computing

BEIJING, Sept. 19, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced the development of a Scalable Quantum Neural Network (SQNN) technology based on multi-quantum-device c...

2025-09-19 23:00 3146

Cheche Group Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

BEIJING, Sept. 19, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"),China's leading auto insurance technology platform, today announced it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq Stock Ma...

2025-09-19 20:30 3955

Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes

SAN FRANCISCO and SUZHOU, China, Sept. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...

2025-09-19 18:01 2576

Baby Shark Teams Up with the London Symphony Orchestra for a 10-Year Celebration

* Set for worldwide release on September 19, featuring a new digital single and a complete vinyl album expanded with an additional track * Special collaboration with the world-renowned London Symphony Orchestra Download image here

2025-09-18 21:00 2167

WiMi Researches a Quantum Machine Learning Framework for Enhanced Privacy Protection

BEIJING, Sept. 18, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that they are committed to developing a hybrid quantum-classical model that combines the acceleration ...

2025-09-18 21:00 1719

EPWK Launches Global Platform, Sets Sights on Becoming a Creative Services Infrastructure Company

XIAMEN, China, Sept. 18, 2025 /PRNewswire/ -- EPWK (NASDAQ: EPWK), the first Chinese AI-powered creative services platform to go public in the U.S., has officially launched its international siteintl.epwk.com , opening a new chapter in its global expansion strategy. With thi...

2025-09-18 20:00 1575

SK Networks successfully hosts "SK Networks AI WAVE 2025" as part of its ongoing commitment to expanding the AI Ecosystem

- Under the theme 'Pitch the Future and Connect the Dots', the event brought together leadingAI startups and investors - The event showcased SK Networks' key AI portfolio companies, including  Upstage and PhnyX Lab - A panel discussion on the future of Sovereign AI featured SK Networks' President ...

2025-09-18 20:00 2134

JinkoSolar Announces Completion of Sale of A Shares in Its Subsidiary, Jinko Solar Co., Ltd., through Inquiry Transfer and Placement

SHANGRAO, China, Sept. 18, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (" JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that the Company has completed the sale of 300,156,075 A shares of Jinko Solar ...

2025-09-18 18:51 2431

iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2025. Second Quarter 2025 Highlights ...

2025-09-18 16:30 4509

iHuman and Cricket Media Team Up to Launch Reading Stars

Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectua...

2025-09-18 16:00 1676

Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2)

SAN FRANCISCO and SUZHOU, China, Sept. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...

2025-09-18 12:00 1792

Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway

Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 17, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings...

2025-09-18 10:28 1980

CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025

SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the updated long-term follow-up results of Phase I clinical trial of zevorcabtagene autoleucel (zevor-cel, R&D code...

2025-09-18 08:15 2131

NAVER CEO Choi Soo-yeon Appointed to UN Global Compact Board of Directors, Strengthening International Partnerships for "AI Governance"

- CEO Choi recognized for her leadership in global dialogues and cooperation to advance safe AI development and establish a digital ecosystem - Sanda Ojiambo, CEO and Executive Director of the UN Global Compact, said, "CEOChoi Soo-yeon's global leadership and deep expertise will be a great asset ...

2025-09-18 08:00 2215

Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025

--Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. --Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. Treatment emergent adverse events (TEAEs)...

2025-09-18 07:30 1739

Xiao-I Corporation Renews Strategic Partnership with Leading Global Bank to Elevate Digital Banking Experience

SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a global leader in artificial intelligence solutions, today announced the successful renewal of its strategic partnership with one of the world's premier financial institutions, a multinational banking organization renown...

2025-09-17 21:45 2511

Cheche Group Expands Partnership with Volkswagen Anhui, Delivering End-to-End Risk Management for New Energy Vehicles

BEIJING, Sept. 17, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced the expansion of its strategic partnership with Volkswagen (Anhui) Automotive Company Limited ("...

2025-09-17 20:30 4256

Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders

SHANGHAI and OAKLAND, Calif., Sept. 17, 2025 /PRNewswire/ -- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio today announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop2MW7141, a novel dual-target siRNA cand...

2025-09-17 20:00 1640

Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

* EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through its partner Qilu Pharmaceutical. DAEJEON, South Korea, Sept. 17, 2025 /PRNewswire/ -- Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has ...

2025-09-17 15:40 2038

111, Inc. Announces Second Quarter 2025 Unaudited Financial Results

* Maintained Quarterly Operational Profitability * Operating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoY * Maintained Positive Operating Cash Flow in the First Half of the Year SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a l...

2025-09-17 14:00 4462
1 ... 42434445464748 ... 779